Related Experiment Videos
Severe transient neonatal hyperammonemia
Insights
Severe transient hyperammonemia in infants, a treatable disorder, affects large premature males. Aggressive treatment, including exchange transfusions, is crucial for survival and normal development.
Area of Science:
- Neonatology
- Pediatric Gastroenterology
- Metabolic Disorders
Background:
- Severe transient hyperammonemia is a critical infant disorder with an unknown cause.
- Affected infants are often large prematures and male.
- Birth asphyxia is frequently associated with this condition.
Purpose of the Study:
- To describe two infants with severe transient hyperammonemia.
- To review the literature and summarize 49 cases.
- To emphasize the need for aggressive treatment regardless of initial ammonia levels.
Main Methods:
- Literature review and case series analysis.
- Summary of 49 cases of severe transient hyperammonemia.
- Analysis of treatment modalities and outcomes.
Main Results:
- Large premature males were most commonly affected.
- Peak plasma ammonium levels did not predict survival.
- Exchange transfusions (ET) or ET with peritoneal dialysis resulted in an 83% survival rate.
- 66% of survivors had normal follow-up examinations.
Conclusions:
- Aggressive therapy is essential for infants with severe transient hyperammonemia.
- Exchange transfusions are an effective treatment modality.
- Increased awareness and considering hemodialysis may further improve outcomes.
Abstract:
Severe transient hyperammonemia is a disorder of unknown etiology which can be successfully treated. This article describes two infants affected by this condition and reviews the pertinent literature. Forty-nine cases, including our own, are summarized. Large prematures (mean birthweight 2534 +/- 738 gm, gestational age 36.1 +/- 4.05 weeks) and infant males most commonly were affected. The peak plasma ammonium concentration did not discriminate between infants who lived and those who died, underscoring the need for aggressive therapy regardless of the initial plasma ammonium concentration. Abnormal liver enzymes were reported in seven cases. Most of these infants were asphyxiated at birth. Exchange transfusions (ET), alone or in combination with peritoneal dialysis, was the most common form of therapy. Of the infants treated with this therapy, 83% survived. Sixty-six percent of the survivors, for which data are available, were normal on follow-up examination. It is not known at present to what extent the associated peritoneal asphyxia was responsible for the observed neurologic sequelae. Increased awareness of this condition and the choice of hemodialysis as a form of therapy may further reduce both morbidity and mortality.